Testosterone slows prostate cancer recurrence in low-risk patients

(European Association of Urology) In the largest such study so far undertaken, US researchers have shown that testosterone replacement slows the recurrence of prostate cancer in low-risk patients. This may call into question the general applicability of Nobel-Prize winning hormonal prostate treatment. The work is presented at the European Association of Urology congress in Barcelona.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2u8CvdJ